本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

TELA Bio, Inc.

1.11
+0.110711.08%
成交量:2.28万
成交额:2.42万
市值:4,477.91万
市盈率:-1.06
高:1.11
开:1.00
低:1.00
收:0.9993
52周最高:3.20
52周最低:0.8645
股本:4,034.15万
流通股本:1,841.61万
量比:1.66
换手率:0.12%
股息:- -
股息率:- -
每股收益(TTM):-1.0487
每股收益(LYR):-1.3265
净资产收益率:-676.41%
总资产收益率:-36.47%
市净率:4.88
市盈率(LYR):-0.84

数据加载中...

2024/10/28

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/25

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/23

重要事件披露

Form 8-K - Current report
2024/10/22

重要事件披露

Form 8-K - Current report
2024/10/01

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/12

重要事件披露

Form 8-K - Current report
2024/07/22

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/07/02

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/06/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/10

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/06/06

重要事件披露

Form 8-K - Current report
2024/05/20

重要事件披露

Form 8-K - Current report
2024/05/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/15

重要事件披露

Form 8-K - Current report
2024/03/22

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/22

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/21

重要事件披露

Form 8-K - Current report
2024/03/20

重要事件披露

Form 8-K - Current report